Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
09/13/2011 | CA2425268C Pyridinone derivatives for treatment of atherosclerosis |
09/13/2011 | CA2396937C Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils |
09/13/2011 | CA2250792C Cocoa extract compounds and methods for making and using the same |
09/09/2011 | WO2011109681A1 Fatty acid cox inhibitor derivatives and their uses |
09/09/2011 | WO2011109587A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators |
09/09/2011 | WO2011109355A1 Compounds for immunoproteasome inhibition |
09/09/2011 | WO2011109324A1 Tetrazole compounds which selectively modulate the cb2 receptor |
09/09/2011 | WO2011108955A1 Multi -targeting system comprising a nanocarrier, nucleic acid(s) and non-nucleic acid based drug(s) |
09/09/2011 | WO2011108644A1 Solid pharmaceutical composition and pharmaceutical preparation |
09/09/2011 | WO2011108499A1 Osteoblast differentiation promoter, pharmaceutical composition for promoting ossification, and health food containing auraptene analog as active ingredient |
09/09/2011 | WO2011108000A1 Isolation of a natural lead with potential of p38 mitogen activated protein kinase and c-jun-n terminal kinase inhibiting activity |
09/09/2011 | WO2011107617A1 Liquid ibuprofen/codeine pharmaceutical composition for oral administration, the method for preparation thereof and use thereof |
09/09/2011 | WO2011107590A1 Cnn1 (cyr61) for prevention and therapy of inflammatory disease |
09/09/2011 | WO2011107248A1 NOVEL COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ GAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASE |
09/09/2011 | WO2011107150A1 Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
09/09/2011 | CA2792003A1 Compositions comprising myristic acid and uses thereof |
09/09/2011 | CA2791805A1 Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
09/09/2011 | CA2791715A1 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators |
09/09/2011 | CA2791691A1 Treatment of lupus nephritis using laquinimod |
09/09/2011 | CA2791651A1 Compounds for immunoproteasome inhibition |
09/08/2011 | US20110218248 Organic compounds |
09/08/2011 | US20110218247 Formulations of low dose diclofenac and beta-cyclodextrin |
09/08/2011 | US20110218225 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
09/08/2011 | US20110218221 Novel histone deacetylase inhibitors, process for preparation and uses thereof |
09/08/2011 | US20110218219 Substituted sulphonamido phenoxybenzamides |
09/08/2011 | US20110218217 Piperidylpropionamide derivatives useful for the treatment of cns disorders including depression and panic disorder |
09/08/2011 | US20110218209 Nutrient delievry drug composition |
09/08/2011 | US20110218207 Isotopically enriched arylsulfonamide ccr3 antagonists |
09/08/2011 | US20110218203 Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate |
09/08/2011 | US20110218201 Novel pyrazolone-derivatives and their use as pde-4 inhibitors |
09/08/2011 | US20110218197 Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators |
09/08/2011 | US20110218191 Use of meloxicam for the long term-treatment of kidney disorders in cats |
09/08/2011 | US20110218189 PYRROLO[2,3-d]PYRIMIDIN-2-YL-AMINE DERIVATIVES AS PKC-THETA INHIBITORS |
09/08/2011 | US20110218186 Spirocyclic heterocyclic derivatives and methods of their use |
09/08/2011 | US20110218180 Esters of Capsaicin for Treating Pain |
09/08/2011 | US20110218178 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases |
09/08/2011 | US20110218172 Composition for down-regulating pro-inflammatory markers |
09/08/2011 | US20110217398 Extract of aerial parts of oats harvested before ear emergence |
09/08/2011 | US20110217394 Iridoid Based Formulations |
09/08/2011 | US20110217387 Pharmaceutical composition for treatment of fibromyalgia |
09/08/2011 | US20110217376 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same |
09/08/2011 | US20110217339 Mucoactive agents for treating a pulmonary disease |
09/08/2011 | US20110217335 Synthesis of resorcylic acid lactones useful as therapeutic agents |
09/08/2011 | US20110217311 Cycloalkyl containing thienopyrimidines for pharmaceutical compositions |
09/08/2011 | US20110217310 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology |
09/08/2011 | US20110217304 Monoclonal antibodies directed to cd52 |
09/08/2011 | US20110217301 Methods for treating or screening for compounds for the treatment of sepsis |
09/08/2011 | US20110217291 Soluble hybrid fct receptors and related methods |
09/08/2011 | US20110217287 Therapeutic composition comprising a botulinum neurotoxin |
09/08/2011 | US20110217272 Treatment of radiation injury using placental stem cells |
09/08/2011 | US20110217271 Treatment of diseases or disorders using placental stem cells |
09/08/2011 | US20110217249 Compositions and Methods for the Treatment of Skin Diseases and Disorders Using Antimicrobial Peptide Sequestering Compounds |
09/08/2011 | US20110217248 Topical Composition |
09/08/2011 | DE102010010288A1 Medicament, useful to prevent or treat e.g. ulcerative colitis, comprises polypeptide sequences of cysteine-rich protein 61 (CCN1) and/or cyclic arginine-glycine-aspartic acid peptide, or nucleic acid encoding polypeptide sequence of CCN1 |
09/07/2011 | EP2363150A1 Compositions and methods for enhancing corticosteroid delivery |
09/07/2011 | EP2363138A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring periodontal diseases |
09/07/2011 | EP2363132A1 The use of sophoricoside in preparing medicaments |
09/07/2011 | EP2363121A1 Pharmaceutical formulation for administration by inhalation comprising an androstane derivative and a beta-2-adrenoreceptor agonist for the treatment of inflammatory and allergic conditions |
09/07/2011 | EP2363120A1 Combinations of dimebolin and memantine |
09/07/2011 | EP2363118A1 Gum resin as a carrier for topical application of pharmacologically active agents |
09/07/2011 | EP2362773A1 Methods for inducing programmed cell death |
09/07/2011 | EP1963288B1 Substituted oxazole derivatives with an analgesic action |
09/07/2011 | EP1853583B1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
09/07/2011 | CN201959273U 一种新型的活血止痛贴膏 A new Huoxuezhitong Plaster |
09/07/2011 | CN1990475B Substituted benzisoselenazolone compounds and use thereof |
09/07/2011 | CN1914182B Quinazoline derivatives |
09/07/2011 | CN1883618B Effective parts of cirald daphne bark, preparation method and application thereof |
09/07/2011 | CN102177180A Alkylated sem-synthetic glycosaminoglycosan ethers, and methods for making and using thereof |
09/07/2011 | CN102177178A Anti-IL-12/IL-23 antibodies |
09/07/2011 | CN102177161A Pyrimidinyl pyridone inhibitors of JNK |
09/07/2011 | CN102177152A Halofuginone analogs for inhibition of tRNA synthetases and uses thereof |
09/07/2011 | CN102177144A Crystalline forms of (R) -5- [3-chloro-4- ( 2, 3-dihydroxy-propoxy) -benz [Z] ylidene] -2- ( [Z] -propylimino) -3-0-tolyl-thiazolidin-4-one |
09/07/2011 | CN102176911A Novel adenine derivatives |
09/07/2011 | CN102174076A Compounds for proteasome enzyme inhibition |
09/07/2011 | CN102174046A Tetomilast polymorphs |
09/07/2011 | CN102174045A Tetomilast polymorphs |
09/07/2011 | CN102174044A Tetomilast polymorphs |
09/07/2011 | CN102174042A Immunosuppressant compounds and compositions |
09/07/2011 | CN102174024A 2,4-pyrimidinediamine compounds and their uses |
09/07/2011 | CN102172403A Method for treating interleukin-6 related diseases |
09/07/2011 | CN102172398A Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins |
09/07/2011 | CN102172397A In vivo targeting of dendritic cells |
09/07/2011 | CN102172370A Method for separating decumbent corydalis tuber total alkaloid with ion exchange resin |
09/07/2011 | CN102172366A Method for separating total alkaloids from motherwort by using ion exchange resin |
09/07/2011 | CN102172365A Method for separating radix sophorae flavescentis total alkaloids by ion exchange resin |
09/07/2011 | CN102172357A Core 2 glcnac-t inhibitors |
09/07/2011 | CN101926826B Method for extracting active ingredients from sea horse |
09/07/2011 | CN101804189B Drug for treating primary dysmenorrhea |
09/07/2011 | CN101785770B Application of methazolamide in preparing medicament for treating ankylosing spondylitis |
09/07/2011 | CN101744804B Application of diacetyl baicalein in preparing antifebrile |
09/07/2011 | CN101703624B Chinese medicinal composition for treating ankylosing spondylitis |
09/07/2011 | CN101700295B Medicinal liquor for relieving dysmenorrhea |
09/07/2011 | CN101664534B External used traditional Chinese medicine for treating scapulohumeral periarthritis |
09/07/2011 | CN101642487B Simultaneous extraction and separation process of baicalin and baicalein in baikal skullcap root |
09/07/2011 | CN101612207B Traditional Chinese medicine for treating headache and preparation method thereof |
09/07/2011 | CN101597337B Conjugate of hydroxyalkyl starch and an active agent |
09/07/2011 | CN101590037B Andrographolidume composition and application thereof |
09/07/2011 | CN101579503B Traditional Chinese medicine for treating rheumatism |
09/07/2011 | CN101569660B External traditional Chinese medicine for relaxing muscles, stimulating blood circulation, diminishing inflammation and relieving pain and preparation method thereof |
09/07/2011 | CN101513522B Chinese medical herbs aerosols for treating anchylosis, painful swelling and preparation method thereof |